External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AATS 2022
Roche and Genentech at

AATS 2022

May 14 - May 17
Boston, USA / Virtual (Hybrid)
aats.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:30 AM
Duration 8mins Hynes Convention Center, Meeting Room 311
Safety and Tolerability of Adjuvant Atezolizumab Following Chemotherapy in Patients With Stage II-IIIA Non-Small Cell Lung Cancer Who Had Pneumonectomy or Bilobectomy: Results From the IMpower010 Trial
Jay M. Lee, Eric Vallieres, Beiying Ding, Ann Johnson, Jan Bhagwakar, Sanam Rashidi, Qian (Cindy) Zhu, Barbara Gitlitz, Benny Weksler, Kimberly Costas, Nasser Altorki
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.